According to the American Cancer Society, prostate cancer is the second-leading cause of cancer-related death in males in the United States, behind only lung cancer. Around 1 out of every 8 men will be diagnosed with prostate cancer at some point in their lives. In most cases, it is treatable, yet there are some cases where all known therapies are met with resistance and things take a turn for the worse. However, a new study involving mouse models revealed that a precursor to vitamin K can potentially slow prostate cancer growth.
Groundbreaking Study on Vitamin K and Cancer
researchers in a lab
Credit: Pexels
A recent discovery at Cold Spring Harbor Laboratory potentially offers a novel solution to the prostate cancer issue. Professor Lloyd Trotman and his team have discovered that the pro-oxidant supplement menadione reduces the development of prostate cancer in studies involving mice. Menadione is found in leafy greens and is a precursor to vitamin K. While this study itself is new, it is the result of another study that took place at the beginning of this century.
ADVERTISEMENT
CHICKEN CACCIATORE
Grandmother’s Stove Still Going Strong
Discover the Joys of Garlic Roasted Eggplants: A Simple and Delicious Recipe
I didn’t know about all the items on this list!
Put raw cabbage wedges in a slow cooker with these 3 ingredients. It’ll wow you.
The Power of Magnesium: A Natural Solution for Bone Pain, Diabetes, Anxiety, and More
Hurricane Approaching the US: Experts Warn of Catastrophic and ‘Unsurvivable’ Impact
How to Defrost Meat: Expert Advice on the Correct Method, Even When You’re Short on Time
Got a dirty car? Here are 10 super clever car cleaning hacks that everyone should know
